Advertisement

International Journal of Hematology

, Volume 79, Issue 3, pp 229–234 | Cite as

Second malignant neoplasms following hematopoietic stem cell transplantation

  • Debra L. Friedman
  • Wendy Leisenring
  • Jeffrey L. Schwartz
  • H. Joachim Deeg
Progress in hematology

Abstract

Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms.We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research.

Key words

Posttransplantation malignancies Secondary cancers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Deeg HJ, Schwartz JL, Friedman D, Leisenring W. Secondary malignancies after hemopoietic stem cell transplantation. Turk J Med Sci. 2003;33:207–214.Google Scholar
  2. 2.
    Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998;91:1833–1844.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Milligan DW. Secondary leukaemia and myelodysplasia after autografting for lymphoma: is the transplant to blame? Leuk Lymphoma. 2000;39:223–228.CrossRefGoogle Scholar
  4. 4.
    Pedersen-Bjergaard J, Andersen MK, Christiansen DH. Therapyrelated acute myeloid leukemia and myelodysplasia after highdose chemotherapy and autologous stem cell transplantation. Blood. 2000;95:3273–3279.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Metayer C, Curtis RE, Vose J, et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood. 2003;101:2015–2023.CrossRefPubMedGoogle Scholar
  6. 6.
    Hosing C, Munsell M, Yazji S, et al. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non- Hodgkin’s lymphoma. Ann Oncol. 2002;13:450–459.CrossRefGoogle Scholar
  7. 7.
    Krishnan A, Bhatia S, Slovak ML, et al. Predictors of therapyrelated leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000;95:1588–1593.PubMedGoogle Scholar
  8. 8.
    Andre M, Henry-Amar M, Blaise D, et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin’s disease. Blood. 1998;92:1933–1940.PubMedGoogle Scholar
  9. 9.
    Kroger N, Zander AR, Martinelli G, et al. Low incidence of secondary myelodysplasia and acute myeloid leukemia after highdose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Ann Oncol. 2003;14:554–558.CrossRefPubMedGoogle Scholar
  10. 10.
    Nichols G, de Castro K, Wei LX, et al. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer. Leukemia. 2002;16:1673–1679.CrossRefPubMedGoogle Scholar
  11. 11.
    Deeg HJ, Witherspoon RP. Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am. 1993;7:417–429.CrossRefPubMedGoogle Scholar
  12. 12.
    Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386–392.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Deeg HJ, Leisenring W, Storb R, et al. Lng-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637–3645.PubMedGoogle Scholar
  14. 14.
    Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001;19:464–471.CrossRefPubMedGoogle Scholar
  15. 15.
    Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633–3639.PubMedGoogle Scholar
  16. 16.
    Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation N Engl J Med. 1997;336:897–904.CrossRefPubMedGoogle Scholar
  17. 17.
    Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18:348–357.CrossRefPubMedGoogle Scholar
  18. 18.
    Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352–1358.CrossRefPubMedGoogle Scholar
  19. 19.
    Rowlings PA, Curtis RE, Passweg JR, et al. Increased incidence of Hodgkin’s disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999;17:3122–3127.CrossRefPubMedGoogle Scholar
  20. 20.
    Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol. 2003;13:248–266.CrossRefPubMedGoogle Scholar
  21. 21.
    Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100:3908–3918.CrossRefPubMedGoogle Scholar
  22. 22.
    Socie G, Loiseau P, Tamouza R, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2001;72:699–706.CrossRefGoogle Scholar
  23. 23.
    Socie G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation. 1998;66:667–670.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Debra L. Friedman
    • 1
  • Wendy Leisenring
    • 1
  • Jeffrey L. Schwartz
    • 1
  • H. Joachim Deeg
    • 1
  1. 1.Fred Hutchinson Cancer Research CenterUniversity of WashingtonSeattleUSA

Personalised recommendations